🇺🇸 FDA
Patent

US 11878012

Compositions and methods for treating traumatic brain injury

granted A61KA61K31/4184A61K31/4709

Quick answer

US patent 11878012 (Compositions and methods for treating traumatic brain injury) held by The Board of Regents of the University of Texas System expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4184, A61K31/4709, A61K45/06, A61P